Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations

Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations

Bader Alsaikhan, Khalid Alrabeeah, Serge CarrierMcGill University Health Centre, Montreal, Quebec, QC, CanadaAbstract: Lower urinary tract symptoms (LUTS) and erectile dysfunction increase with age. Several studies have identified a true association between these two disorders. Basic research studie...

Full description

Bibliographic Details
Main Authors:	Alsaikhan B, Alrabeeah K, Carrier S
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-06-01
Series:	International Journal of General Medicine
Online Access:	http://www.dovepress.com/management-options-for-the-treatment-of-benign-prostatic-hyperplasia-w-a17192

Similar Items

A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction
by: Konstantinos Hatzimouratidis
Published: (2014-08-01)

Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia and Erectile Dysfunction
by: Zhongbao Zhou, et al.
Published: (2019-10-01)

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction
by: Gacci M, et al.
Published: (2013-04-01)

Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
by: Chris Olesovsky, et al.
Published: (2016-08-01)

The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia
by: Oka AAG, et al.
Published: (2019-04-01)

Diagnosis and treatment of erectile dysfunction in patients with benign prostatic hyperplasia
by: S. N. Kalinina, et al.
Published: (2016-04-01)

Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations
by: Lee LK, et al.
Published: (2016-07-01)

Phytopreparations in complex treatment of patients with benign prostatic hyperplasia and erectile dysfunction
by: A. B. Bat’ko
Published: (2018-12-01)

Combination of tadalafil and finasteride for improving the symptoms of benign prostatic hyperplasia: critical appraisal and patient focus
by: Elkelany OO, et al.
Published: (2015-03-01)

Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies
by: O'Leary Michael P, et al.
Published: (2010-11-01)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
by: Muhammed M. Qalawena, MD, et al.
Published: (2020-06-01)

Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
by: Yu Seob Shin, et al.
Published: (2019-05-01)

PHARMACOTHERAPY IN PATIENTS WITH ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA IN THE ABSENCE OF RISK OF DISEASE PROGRESSION
by: A. A. Kamalov, et al.
Published: (2018-03-01)

Treatment persistence with a fixed-dose combination of tadalafil (5 mg) and tamsulosin (0.4 mg) and reasons for early discontinuation in patients with benign prostatic hyperplasia and erectile dysfunction
by: Sun Tae Ahn, et al.
Published: (2020-01-01)

Tadalafil therapy for erectile dysfunction following prostatectomy
by: Ateş Kadıoğlu, et al.
Published: (2015-06-01)

Improvement of the symptoms of lower urinary tract and sexual dysfunction with tadalafil and solifenacin after the treatment of benign prostatic hyperplasia with dutasteride
by: Kirill V. Kosilov, et al.
Published: (2020-06-01)

Efficacy and safety of combination treatment with tadalafil and mirabegron for persistent storage symptoms despite tadalafil treatment in patients with benign prostatic hyperplasia
by: M. Honda, et al.
Published: (2020-07-01)

Relationship between Dietary Patterns with Benign Prostatic Hyperplasia and Erectile Dysfunction: A Collaborative Review
by: Giorgio Ivan Russo, et al.
Published: (2021-11-01)

Pathogenic mechanisms linking benign prostatic hyperplasia, lower urinary tract symptoms and erectile dysfunction
by: Sidney Glina, et al.
Published: (2013-08-01)

New approaches to management of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia
by: S. I. Gamidov, et al.
Published: (2019-10-01)

Does tadalafil prevent erectile dysfunction in patients undergoing radiation therapy for prostate cancer?
by: Luca Incrocci
Published: (2014-10-01)

The role of tadalafil in treated hypertensive patients with erectile dysfunction
by: Ehud Grossman
Published: (2022-02-01)

Therapeutic options in the treatment of benign prostatic hyperplasia
by: Jaspreet S Sandhu
Published: (2009-08-01)

Effect of Tadalafil on Penile Duplex parameters in Erectile Dysfunction Patients
by: Ali Mohamed Younis, et al.
Published: (2023-07-01)

Effect of tadalafil on erectile dysfunction in male patients with diabetes mellitus
by: Popović Srđan, et al.
Published: (2007-01-01)

Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives
by: Pierre Costa, et al.
Published: (2009-04-01)

Evaluation of the effect of sildenafil and/or doxazosin on Benign prostatic hyperplasia-related lower urinary tract symptoms and erectile dysfunction
by: Ahmed Abolyosr, et al.
Published: (2013-01-01)

Evaluation of Tadalafil effect on lower urinary tract symptoms of benign prostatic hyperplasia in patients treated with standard medication
by: Ali Hamidi Madani, et al.
Published: (2012-02-01)

A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy
by: Samuel L Washington III, et al.
Published: (2010-08-01)

The efficacy and safety of tadalafil in the management of erectile dysfunction with diabetes and blood circulation issues
by: Jong Seung Lee, et al.
Published: (2023-12-01)

Meta-Analysis of the Long-Term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction
by: Zhongbao Zhou, MM, et al.
Published: (2019-09-01)

Comparison of impact of monopolar versus bipolar resection of the prostate on erectile function in patients with benign hyperplasia of the prostate
by: G. El Shorbagy, et al.
Published: (2018-09-01)

Effectiveness of tadalafil and tamsulosin combination in benign prostatic hyperplasia: A prospective cohort study at a tertiary care center
by: Sudarsan S, et al.
Published: (2023-08-01)

Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia
by: Daisuke Gotoh, et al.
Published: (2022-09-01)

A randomized clinical trial to evaluate efficacy and safety of monotherapy with tadalafil or tamsulosin and their combination in men with benign prostatic hyperplasia
by: M. Bibi, et al.
Published: (2020-07-01)

Tadalafil vs Tamsulosin for the Management of Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia: A Randomised Clinical Trial
by: A Venkata Ranga Swamy, et al.
Published: (2023-09-01)

Does the Daily Dose of Tadalafil for the Treatment of Erectile Dysfunction Increase Penile Sensation?
by: Selim Taş, et al.
Published: (2023-03-01)

Proniosomal Gel-Loaded Phosphodiesterase Inhibitors (Sildenafil, Vardenafil, and Tadalafil): Prospects for Topical Penile Therapy of Tadalafil for Treatment of Erectile Dysfunction
by: Soad A. Mohamed, et al.
Published: (2023-07-01)

Future prospects in the treatment of erectile dysfunction: focus on avanafil
by: Alwaal A, et al.
Published: (2011-10-01)

Benign Prostatic Hyperplasia
Published: (2015-01-01)